Oriol, A. Et Al. 2024. Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.24, no.3 , 165-0.

Oriol, A., Dimopoulos, M., Schjesvold, F., Beksac, M., Facon, T., Dhanasiri, S., ... Guo, S.(2024). Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.24, no.3, 165-0.

Oriol, Albert Et Al. "Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.24, no.3, 165-0, 2024

Oriol, Albert Et Al. "Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.24, no.3, pp.165-0, 2024

Oriol, A. Et Al. (2024) . "Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.24, no.3, pp.165-0.

@article{article, author={Albert Oriol Et Al. }, title={Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2024, pages={165-0} }